S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Five Prime TherapeuticsAraviveMonopar TherapeuticsNature's Sunshine ProductsOvid Therapeutics
SymbolNASDAQ:FPRXNASDAQ:ARAVNASDAQ:MNPRNASDAQ:NATRNASDAQ:OVID
Price Information
Current Price$5.20$8.57$10.32$10.08$3.42
52 Week RangeHoldBuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyN/ABuy
Consensus Price Target$12.25$28.50$42.00N/A$14.80
% Upside from Price Target135.58% upside232.56% upside306.79% upsideN/A332.76% upside
Trade Information
Market Cap$195.06 million$125.99 million$105.35 million$198.92 million$169.27 million
Beta2.532.5N/A0.622.86
Average Volume390,902115,10118,26812,308500,806
Sales & Book Value
Annual Revenue$49.87 million$1.37 millionN/A$364.81 millionN/A
Price / Sales3.7991.64N/A0.53N/A
CashflowN/AN/AN/A$0.45 per shareN/A
Price / CashN/AN/AN/A22.47N/A
Book Value$7.48 per share$5.36 per shareN/A$6.28 per share$1.57 per share
Price / Book0.701.60N/A1.61N/A
Profitability
Net Income$-140,450,000.00$-76,330,000.00$-3,230,000.00$-850,000.00$-51,980,000.00
EPS($4.13)($10.64)N/AN/A($2.11)
Trailing P/E RatioN/AN/A0.0067.20N/A
Forward P/E RatioN/AN/AN/A∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-921.30%N/AN/A0.77%N/A
Return on Equity (ROE)-65.39%-49.37%-69.67%4.65%-131.50%
Return on Assets (ROA)-48.66%-39.24%-64.14%2.76%-107.46%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/A-100.00%N/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.26%0.18%N/A0.17%0.01%
Current Ratio6.93%7.59%10.56%1.74%3.78%
Quick Ratio6.93%7.59%10.56%1.01%3.78%
Ownership Information
Institutional Ownership Percentage72.10%42.87%0.25%77.54%37.16%
Insider Ownership Percentage7.10%39.80%N/A20.30%29.80%
Miscellaneous
Employees20914490555
Shares Outstanding36.39 million14.65 million10.59 million19.33 million47.82 million
Next Earnings Date2/27/2020 (Confirmed)3/5/2020 (Estimated)N/A3/5/2020 (Estimated)3/5/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel